Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment
Sara Volpi(University of Modena and Reggio Emilia), Marianna Meschiari(Azienda Ospedaliero-Universitaria di Modena), Gabriele Melegari(Azienda Ospedaliero-Universitaria di Modena), Stefania Casolari(Azienda Ospedaliero-Universitaria di Modena), Mario Sarti(Azienda Ospedaliero-Universitaria di Modena), Shaniko Kaleci(University of Modena and Reggio Emilia), Lucia Serio(University of Modena and Reggio Emilia), Adriana Cervo(Azienda Ospedaliero-Universitaria di Modena), Antonello Pietrangelo(Policlinico di Modena), Erica Franceschini(University of Modena and Reggio Emilia), Irene Venturelli(University of Modena and Reggio Emilia), Roberto Tonelli(University of Modena and Reggio Emilia), Davide Chemello(University of Modena and Reggio Emilia), Stefano Busani(University of Modena and Reggio Emilia), Paola Buonadonna(University of Modena and Reggio Emilia), Gabriella Orlando(University of Modena and Reggio Emilia), Massimo Girardis(University of Modena and Reggio Emilia), Claudia Venturelli(Azienda Ospedaliero-Universitaria di Modena), Giovanni Pinelli(Azienda Unita' Sanitaria Locale Di Modena), Cristina Mussini(University of Modena and Reggio Emilia), Sara Esperti(University of Modena and Reggio Emilia), Samuele Cantergiani(Azienda Ospedaliero-Universitaria di Modena), Lucio Brugioni(Azienda Ospedaliero-Universitaria di Modena), Andrea Bedini(Azienda Ospedaliero-Universitaria di Modena), Jacopo Baldi(University of Modena and Reggio Emilia), M. Albertini(Azienda Ospedaliero-Universitaria di Modena), Laura Cancian(Azienda Ospedaliero-Universitaria di Modena)
Cited by 3
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738